2017 Annual Meeting

Session: Model Based Integrated Design of Pharmaceutical Drug Product Processes

session seeks contributions where modeling-aided approaches as well as optimization techniques have been applied for decision making in the design and development of pharmaceutical intermediates, and/or drug products. Modeling research using deterministic models derived from fundamental principles are all in scope for this session. Authors are encouraged to highlight integration to upstream and downstream operations as well as Quality by Design considerations.

Chair

Ricart, B. G., Merck & Co., Inc.

Co-Chair

Yazdanpanah, N., Food and Drug Administration